Alzheimers

a53

APOLIPOPROTEIN E (APOE)

refers to a protein that may help break down beta-amyloid. Individuals carrying a ApoE4 allele, are statistically more likely to

BASAL FOREBRAIN

n. area of the brain responsible for memory, learning, and attention. Includes the cerebral cortex and hippocampus. When acetylcholine is

BETA-AMYLOID (P-AMYLOID)

n. a type of protein deposit found in the brain tissue of patients having Alzheimer's disease. This deposit contains peptides

BETA-SECRETASE (P-SECRETASE)

n. a protein enzyme (protease) which cleaves the amyloid precursor protein to form beta-amyloid. These are the peptides which build-up

BOSTON NAMING TEST (BNT)

n. a test in word retrieval designed for patients experiencing language disturbance such as those caused by dementia, stroke, and

BUTYRYLCHOLINESTERASE

n. a synthetic, non-specific cholinesterase enzyme identified in the liver and related tissues. It assists in regulating the level of

CANCELLATION TEST

n. A neuropsychological test which assesses perceptual and motor speed. From a given list of items randomly-distributed on a page

CONFUSIONAL STATE

a condition of handicapped intellectual operations wherein consciousness is maintained but with deprivation of intellectual comprehensibility and orientation to time,

CORTICAL DEMENTIA

dementia which stems from weakening of the cortical regions of the brain, instead of the subcortical regions. Most frequently occurring

DAT 1

1. abbreviated form of the Alzheimer's form of dementia. 2. abbreviated form of Differential Aptitude Tests.

ACETYLCHOLINESTERASE INHIBITORS

drugs that obstruct the capacity of the molecule acetyl cholinesterase to diminish the neurotransmitter acetylcholine in the synaptic cholinergic neurons.

AGE-APPROPRIATE MATURITY

emotional or mental readiness: the capacity to handle something very well and recover from well, with experience and to carry